Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
DNMR Stock Forecast 2026-2027
$0.35
Current Price
$3.41M
Market Cap
Buy 0
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to DNMR Price Targets
+1,185.7%
To High Target of $4.50
+1,185.7%
To Median Target of $4.50
+1,185.7%
To Low Target of $4.50
DNMR Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
-77.1%
1 Year Change
0.0%
Year-to-Date Change
-92.6%
From 52W High of $4.74
+7.7%
From 52W Low of $0.32
📊 TOP ANALYST CALLS
Did DNMR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Danimer is one of their latest high-conviction picks.
Latest DNMR Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, DNMR has a neutral consensus with a median price target of $4.50 (ranging from $4.50 to $4.50). The overall analyst rating is N/A (N/A/10). Currently trading at $0.35, the median forecast implies a 1,185.7% upside. This outlook is supported by 0 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Charles Neivert at Piper Sandler, projecting a 1,185.7% upside. Conversely, the most conservative target is provided by Charles Neivert at Piper Sandler, suggesting a 1,185.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DNMR Analyst Ratings
0
Buy
1
Hold
0
Sell
DNMR Price Target Range
Low
$4.50
Average
$4.50
High
$4.50
Current: $0.35
Latest DNMR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DNMR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 21, 2024 | Piper Sandler | Charles Neivert | Neutral | Maintains | $1.00 |
| Aug 13, 2024 | TD Cowen | Hold | Downgrade | $N/A | |
| May 22, 2024 | Jefferies | Laurence Alexander | Hold | Downgrade | $0.80 |
| Apr 9, 2024 | Piper Sandler | Charles Neivert | Neutral | Downgrade | $1.25 |
| Apr 4, 2024 | TD Cowen | Thomas Boyes | Buy | Maintains | $2.00 |
| Oct 11, 2023 | Piper Sandler | Charles Neivert | Overweight | Maintains | $4.00 |
| Jun 1, 2023 | Piper Sandler | Charles Neivert | Overweight | Maintains | $8.00 |
| Apr 3, 2023 | Piper Sandler | Charles Neivert | Overweight | Maintains | $7.00 |
| Oct 12, 2022 | Piper Sandler | Charles Neivert | Overweight | Initiates | $4.50 |
| Sep 23, 2021 | Cowen & Co. | Thomas Boyes | Outperform | Initiates | $21.00 |
Danimer Scientific Inc. (DNMR) Competitors
The following stocks are similar to Danimer based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Danimer Scientific Inc. (DNMR) Financial Data
Danimer Scientific Inc. has a market capitalization of $3.41M with a P/E ratio of 0.0x. The company generates $37.43M in trailing twelve-month revenue with a -297.1% profit margin.
Revenue growth is -21.2% quarter-over-quarter, while maintaining an operating margin of -217.3% and return on equity of -43.1%.
Valuation Metrics
Market Cap
$3.41M
Enterprise Value
$391.60M
P/E Ratio
0.0x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
-21.2%
Gross Margin
-84.8%
Operating Margin
-217.3%
Net Margin
-297.1%
EPS Growth
-21.2%
Financial Health
Cash/Price Ratio
+2,099.1%
Current Ratio
3.3x
Debt/Equity
195.2x
ROE
-43.1%
ROA
-8.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Danimer Scientific Inc. (DNMR) Business Model
About Danimer Scientific Inc.
What They Do
Develops biodegradable plastics as eco-friendly alternatives.
Business Model
Danimer Scientific generates revenue by developing and producing biodegradable plastics, specifically polyhydroxyalkanoate (PHA) based materials. These products cater to sectors focused on sustainability, such as packaging, consumer goods, and agriculture, allowing companies to reduce plastic waste and comply with environmental regulations.
Additional Information
The company's growth is supported by the increasing global demand for sustainable solutions and strong ESG credentials, making it an attractive investment in the expanding bioplastics market.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
257
CEO
Mr. Richard N. Altice
Country
United States
IPO Year
2012
Website
danimerscientific.comDanimer Scientific Inc. (DNMR) Latest News & Analysis
Latest News
Quick Summary
The NYSE will delist Danimer Scientific, Inc. (DNMR) due to regulatory decisions, with trading suspended immediately.
Why It Matters
Delisting from the NYSE signals serious financial issues for Danimer Scientific, potentially leading to diminished investor confidence and a decline in stock value.
Source: Business Wire
Market Sentiment:
Neutral
Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace
1 year ago
Quick Summary
Danimer Scientific, Inc. (NYSE: DNMR) has been notified that trading of its stock has been suspended and the delisting process from the NYSE has begun.
Why It Matters
Danimer Scientific's suspension and potential delisting from the NYSE signal financial instability, which can negatively impact stock value and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Danimer Scientific, Inc. (NYSE: DNMR) issued an $11.25 million super senior secured promissory note to lenders under its term loan financing agreement.
Why It Matters
Danimer Scientific's issuance of a secured promissory note indicates potential funding for growth or operations, which could impact its financial stability and attractiveness to investors.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
TerraNova Capital Equities' Structure Finance Group advised Danimer Scientific, Inc. on a $20 million revolving credit facility.
Why It Matters
TerraNova's advisory role in securing a $20M credit facility for Danimer Scientific could enhance the company's liquidity and growth potential, impacting its stock performance and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Danimer Scientific, Inc. (NYSE: DNMR) will hold its Q3 2024 earnings call on November 19, 2024, at 10:00 AM ET, featuring Interim CEO Rich Altice and CFO Mike Hajost.
Why It Matters
Danimer Scientific's Q3 2024 earnings call may reveal financial performance, strategic direction, and market outlook, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Danimer Scientific (NYSE: DNMR) reported its Q3 financial results for 2024, aligning with expectations despite a temporary impact from Starbucks' reapportionment.
Why It Matters
Danimer Scientific's Q3 results reflect stability despite challenges from a key client, indicating resilience in its business model, which may affect investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About DNMR Stock
What is Danimer Scientific Inc.'s (DNMR) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Danimer Scientific Inc. (DNMR) has a median price target of $4.50. The highest price target is $4.50 and the lowest is $4.50.
Is DNMR stock a good investment in 2026?
According to current analyst ratings, DNMR has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.35. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for DNMR stock?
Wall Street analysts predict DNMR stock could reach $4.50 in the next 12 months. This represents a 1,185.7% increase from the current price of $0.35. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Danimer Scientific Inc.'s business model?
Danimer Scientific generates revenue by developing and producing biodegradable plastics, specifically polyhydroxyalkanoate (PHA) based materials. These products cater to sectors focused on sustainability, such as packaging, consumer goods, and agriculture, allowing companies to reduce plastic waste and comply with environmental regulations.
What is the highest forecasted price for DNMR Danimer Scientific Inc.?
The highest price target for DNMR is $4.50 from Charles Neivert at Piper Sandler, which represents a 1,185.7% increase from the current price of $0.35.
What is the lowest forecasted price for DNMR Danimer Scientific Inc.?
The lowest price target for DNMR is $4.50 from Charles Neivert at Piper Sandler, which represents a 1,185.7% increase from the current price of $0.35.
What is the overall DNMR consensus from analysts for Danimer Scientific Inc.?
The overall analyst consensus for DNMR is neutral. Out of 4 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $4.50.
How accurate are DNMR stock price projections?
Stock price projections, including those for Danimer Scientific Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 18, 2026 9:48 PM UTC